{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:48:51Z","timestamp":1773298131412,"version":"3.50.1"},"publisher-location":"Berlin, Heidelberg","reference-count":52,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783540889540","type":"print"},{"value":"9783540889557","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009]]},"DOI":"10.1007\/978-3-540-88955-7_17","type":"book-chapter","created":{"date-parts":[[2009,8,12]],"date-time":"2009-08-12T22:02:39Z","timestamp":1250114559000},"page":"397-410","source":"Crossref","is-referenced-by-count":3,"title":["Tourette\u2019s Syndrome"],"prefix":"10.1007","author":[{"given":"Kirsten R.","family":"M\u00fcller-Vahl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,24]]},"reference":[{"key":"17_CR1_17","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1016\/0024-3205(95)00194-B","volume":"56","author":"A Abrahamov","year":"1995","unstructured":"Abrahamov A, Abrahamov A, Mechoulam R (1995) An efficient new cannabinoid antiemetic in pediatric oncology. Life Sci 56:2097\u20132102","journal-title":"Life Sci"},{"key":"17_CR2_17","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.neubiorev.2003.08.007","volume":"2","author":"W Adriani","year":"2003","unstructured":"Adriani W, Caprioli A, Granstrem O et al. (2003) The spontaneously hypertensive-rat as an animal model of ADHD: evidence for impulsive and non-impulsive subpopulations. Neurosci Biobehav Rev 2:639\u2013651","journal-title":"Neurosci Biobehav Rev"},{"key":"17_CR3_17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0079-6123(08)62678-3","volume":"85","author":"GE Alexander","year":"1990","unstructured":"Alexander GE, Crutcher MD, DeLong MR (1990) Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, \"prefrontal\" and \"limbic\" functions. Prog Brain Res 85:119\u2013146","journal-title":"Prog Brain Res"},{"key":"17_CR4_17","first-page":"273","volume":"59","author":"AL Benton","year":"1945","unstructured":"Benton AL (1945) A visual retention test for clinical use. Arch Neurol Psychol 59:273\u2013291","journal-title":"Arch Neurol Psychol"},{"key":"17_CR5_17","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.biopsych.2004.01.005","volume":"55","author":"G Berding","year":"2004","unstructured":"Berding G, M\u00fcller-Vahl K, Schneider U et al. (2004) [123I]AM281 single-photon emission computed tomography imaging of central cannabinoid CB1 receptors before and after Delta9-tetrahydrocannabinol therapy and whole-body scanning for assessment of radiation dose in tourette patients. Biol Psychiatry 55:904\u2013915","journal-title":"Biol Psychiatry"},{"key":"17_CR6_17","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/BF02246977","volume":"110","author":"RI Block","year":"1993","unstructured":"Block RI, Ghoneim MM (1993) Effects of chronic marijuana use on human cognition. Psychopharmacology (Berl) 110:219\u2013228","journal-title":"Psychopharmacology (Berl)"},{"key":"17_CR7_17","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1046\/j.1471-4159.1997.69031131.x","volume":"69","author":"AK Cadogan","year":"1997","unstructured":"Cadogan AK, Alexander SP, Boyd EA et al. (1997) Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum. J Neurochem 69:1131\u20131137","journal-title":"J Neurochem"},{"key":"17_CR8_17","unstructured":"Derogatis LR (1977) SCL 90. Administration, scoring and procedures. Manual-I for the R(evised) version and other instruments of the psychopathology rating scale series. John Hopkins University School of Medicine"},{"key":"17_CR9_17","first-page":"13","volume":"9","author":"LR Derogatis","year":"1973","unstructured":"Derogatis LR, Lipman RS, Covi L (1973) SCL-90: an outpatient psychiatric rating scale\u2013preliminary report. Psychopharmacol Bull 9:13\u201328","journal-title":"Psychopharmacol Bull"},{"key":"17_CR10_17","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1096\/fj.14.10.1432","volume":"14","author":"V Marzo Di","year":"2000","unstructured":"Di Marzo V, Hill MP, Bisogno T et al. (2000) Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease. FASEB J 14:1432\u20131438","journal-title":"FASEB J"},{"key":"17_CR11_17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1017\/S0033291702006402","volume":"33","author":"DM Fergusson","year":"2003","unstructured":"Fergusson DM, Horwood LJ, Swain-Campbell NR (2003) Cannabis dependence and psychotic symptoms in young people. Psychol Med 33:15\u201321","journal-title":"Psychol Med"},{"key":"17_CR12_17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/ajmg.b.20159","volume":"127","author":"D Gadzicki","year":"2004","unstructured":"Gadzicki D, M\u00fcller-Vahl KR, Heller D et al. (2004) Tourette syndrome is not caused by mutations in the central cannabinoid receptor (CNR1) gene. Am J Med Genet B Neuropsychiatr Genet 127:97\u2013103","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"17_CR13_17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0022-3999(02)00581-0","volume":"55","author":"E Gerard","year":"2003","unstructured":"Gerard E, Peterson BS (2003) Developmental processes and brain imaging studies in Tourette syndrome. J Psychosom Res 55:13\u201322","journal-title":"J Psychosom Res"},{"key":"17_CR14_17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0014-2999(97)01442-8","volume":"341","author":"GL Gessa","year":"1998","unstructured":"Gessa GL, Melis M, Muntoni AL et al. (1998) Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. Eur J Pharmacol 341:39\u201344","journal-title":"Eur J Pharmacol"},{"key":"17_CR15_17","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/7268","volume":"2","author":"A Giuffrida","year":"1999","unstructured":"Giuffrida A, Parsons LH, Kerr TM et al. (1999) Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci 2:358\u2013363","journal-title":"Nat Neurosci"},{"key":"17_CR16_17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0306-4522(96)00428-9","volume":"77","author":"M Glass","year":"1997","unstructured":"Glass M, Dragunow M, Faull RL (1997) Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 77:299\u2013318","journal-title":"Neuroscience"},{"key":"17_CR17_17","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1212\/WNL.37.9.1542","volume":"37","author":"CG Goetz","year":"1987","unstructured":"Goetz CG, Tanner CM, Wilson RS et al. (1987) A rating scale for Gilles de la Tourette's syndrome: description, reliability, and validity data. Neurology 37:1542\u20131544","journal-title":"Neurology"},{"key":"17_CR18_17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/00004583-198403000-00006","volume":"23","author":"DF Harcherik","year":"1984","unstructured":"Harcherik DF, Leckman JF, Detlor J et al. (1984) A new instrument for clinical studies of Tourette\u2019s syndrome. Am J Acad Child Psychiatry 23:153\u2013160","journal-title":"Am J Acad Child Psychiatry"},{"key":"17_CR19_17","first-page":"21","volume":"141","author":"C Helmstaedter","year":"1990","unstructured":"Helmstaedter C, Durwen HF (1990) VLMT. Verbaler Lern- und Merkf\u00e4higkeitstest. Schweiz Arch Neurol Psychiatr 141:21\u201330","journal-title":"Schweiz Arch Neurol Psychiatr"},{"key":"17_CR20_17","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1177\/026988119300700411","volume":"7","author":"M Hemming","year":"1993","unstructured":"Hemming M, Yellowlees PM (1993) Effective treatment of Tourette\u2019s syndrome with marijuana. J Psychopharmacol 7:389\u2013391","journal-title":"J Psychopharmacol"},{"key":"17_CR21_17","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","volume":"87","author":"M Herkenham","year":"1990","unstructured":"Herkenham M, Lynn AB, Little MD et al. (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87:1932\u20131936","journal-title":"Proc Natl Acad Sci U S A"},{"key":"17_CR22_17","volume-title":"Tourette\u2019s syndrome and tic disorders","author":"JF Leckman","year":"1988","unstructured":"Leckman JF, Towbin KE, Ort SI et al. (1988) Clinical assessment of tic disorder severity. In: Cohen DJ, Bruun RD, Leckman JF (eds) Tourette\u2019s syndrome and tic disorders. Wiley, New York"},{"key":"17_CR23_17","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1111\/j.1471-4159.1993.tb09807.x","volume":"61","author":"P Mailleux","year":"1993","unstructured":"Mailleux P, Vanderhaeghen JJ (1993) Dopaminergic regulation of cannabinoid receptor mRNA levels in the rat caudate-putamen: an in situ hybridization study. J Neurochem 61:1705\u20131712","journal-title":"J Neurochem"},{"key":"17_CR24_17","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1089\/cap.2004.14.582","volume":"14","author":"BJ Mantel","year":"2004","unstructured":"Mantel BJ, Meyers A, Tran QY et al. (2004) Nutritional supplements and complementary\/alternative medicine in Tourette syndrome. J Child Adolesc Psychopharmacol 14:582\u2013589","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"17_CR25_17","first-page":"423","volume":"27","author":"J Merz","year":"1975","unstructured":"Merz J, Lehrl S, Galster JV et al. (1975) MWT-B \u2013 ein Intelligenzkurztest. Psychiatr Neurol Med Psychol 27:423\u2013428","journal-title":"Psychiatr Neurol Med Psychol"},{"key":"17_CR26_17","first-page":"113","volume":"85","author":"JM Mink","year":"2001","unstructured":"Mink JM (2001) Neurobiology of basal ganglia circuit in Tourette Syndrome: faulty inhibition of unwanted motor patterns? Adv Neurol 85:113\u2013122","journal-title":"Adv Neurol"},{"key":"17_CR27_17","volume-title":"The cannabinoids: chemical, pharmacologic, and therapeutic aspects","author":"DE Moss","year":"1984","unstructured":"Moss DE, Montgomery SP, Salo AA et al. (1984) Tetrahydrocannabinol effects on extrapyramidal motor behaviors in an animal model of Parkinson\u2019s disease. In: Agurell S, Dewey WL, Willette RE (eds) The cannabinoids: chemical, pharmacologic, and therapeutic aspects. Academic Press, New York"},{"key":"17_CR28_17","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/0024-3205(89)90444-X","volume":"44","author":"DE Moss","year":"1989","unstructured":"Moss DE, Manderscheid PZ, Montgomery SP et al. (1989) Nicotine and cannabinoids as adjuncts to neuroleptics in the treatment of Tourette syndrome and other motor disorders. Life Sci 44:1521\u20131525","journal-title":"Life Sci"},{"key":"17_CR29_17","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1517\/14656566.3.7.899","volume":"3","author":"KR M\u00fcller-Vahl","year":"2002","unstructured":"M\u00fcller-Vahl KR (2002) The treatment of Tourette\u2019s syndrome: current opinions. Expert Opin Pharmacother 3:899\u2013914","journal-title":"Expert Opin Pharmacother"},{"key":"17_CR30_17","first-page":"II19","volume":"256","author":"KR M\u00fcller-Vahl","year":"2006","unstructured":"M\u00fcller-Vahl KR (2006) Involvement of fronto-striatal pathways in Tourette syndrome with and without comorbid ADHD and OCD. Eur Arch Psychiatry Clin Neurosci 256:II19","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"17_CR31_17","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1212\/WNL.48.5.1478-b","volume":"48","author":"KR M\u00fcller-Vahl","year":"1997","unstructured":"M\u00fcller-Vahl KR, Kolbe H, Dengler R (1997a) Alcohol withdrawal and Tourette\u2019s syndrome. Neurology 48:1478\u20131479","journal-title":"Neurology"},{"key":"17_CR32_17","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s001150050227","volume":"68","author":"KR M\u00fcller-Vahl","year":"1997","unstructured":"M\u00fcller-Vahl KR, Kolbe H, Dengler R (1997b) Gilles de la Tourette syndrome. Effect of nicotine, alcohol and marihuana on clinical symptoms. Nervenarzt 68:985\u2013989","journal-title":"Nervenarzt"},{"key":"17_CR33_17","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/j.1600-0447.1998.tb10127.x","volume":"98","author":"KR M\u00fcller-Vahl","year":"1998","unstructured":"M\u00fcller-Vahl KR, Kolbe H, Schneider U et al. (1998) Cannabinoids: Possible role in pathophysiology of Gilles de la Tourette-syndrome. Acta Psychiat Scand 98:502\u2013506","journal-title":"Acta Psychiat Scand"},{"key":"17_CR34_17","first-page":"395","volume":"156","author":"KR M\u00fcller-Vahl","year":"1999","unstructured":"M\u00fcller-Vahl KR, Schneider U, Kolbe H et al. (1999) Treatment of Tourette-syndrome with delta-9-Tetrahydrocannabinol. Am J Psychiatry 156:395","journal-title":"Am J Psychiatry"},{"key":"17_CR35_17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1055\/s-2001-15191","volume":"34","author":"KR M\u00fcller-Vahl","year":"2001","unstructured":"M\u00fcller-Vahl KR, Koblenz A, Jobges M et al. (2001) Influence of delta-9-Tetrahydrocannabinol (\u03949-THC) treatment of Tourette-syndrome on neuropsychological testing. Pharmacopsychiatry 34:19\u201324","journal-title":"Pharmacopsychiatry"},{"key":"17_CR36_17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1300\/J175v02n03_10","volume":"2","author":"KR M\u00fcller-Vahl","year":"2002","unstructured":"M\u00fcller-Vahl KR, Schneider U, Emrich HM (2002a) Combined treatment of Tourette-syndrome with \u03949-THC and dopamine receptor antagonists. J Cannabis Ther 2:145\u2013154","journal-title":"J Cannabis Ther"},{"key":"17_CR37_17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1055\/s-2002-25028","volume":"35","author":"KR M\u00fcller-Vahl","year":"2002","unstructured":"M\u00fcller-Vahl KR, Schneider U, Koblenz A et al. (2002b) Treatment of Tourette-syndrome with \u03949-Tetrahydrocannabinol (THC). Pharmacopsychiatry 35:57\u201361","journal-title":"Pharmacopsychiatry"},{"key":"17_CR38_17","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/sj.npp.1300047","volume":"28","author":"KR M\u00fcller-Vahl","year":"2003","unstructured":"M\u00fcller-Vahl KR, Prevedel H, Theloe K et al. (2003a) Treatment of Tourette-syndrome with \u03949-Tetrahydrocannabinol (\u03949-THC): no influence on neuropsychological performance. Neuropsychopharmacology 28:384\u2013388","journal-title":"Neuropsychopharmacology"},{"key":"17_CR39_17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.4088\/JCP.v64n0417","volume":"64","author":"KR M\u00fcller-Vahl","year":"2003","unstructured":"M\u00fcller-Vahl KR, Schneider U, Prevedel H et al. (2003b) \u03949-Tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette-Syndrome: a 6-week randomized trial. J Clin Psychiatry 64:459\u2013465","journal-title":"J Clin Psychiatry"},{"key":"17_CR40_17","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/j.1651-2227.2008.00675.x","volume":"97","author":"KR M\u00fcller-Vahl","year":"2008","unstructured":"M\u00fcller-Vahl KR, Buddensiek N, Geomelas M et al. (2008) The influence of different food and drink on tics in Tourette syndrome. Acta Paediatr 97:442\u2013446","journal-title":"Acta Paediatr"},{"key":"17_CR41_17","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1136\/bmj.325.7374.1195","volume":"325","author":"GC Patton","year":"2002","unstructured":"Patton GC, Coffey C, Carlin JB et al. (2002) Cannabis use and mental health in young people: cohort study. BMJ 325:1195\u20131198","journal-title":"BMJ"},{"key":"17_CR42_17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/brain\/123.3.425","volume":"123","author":"MM Robertson","year":"2000","unstructured":"Robertson MM (2000) Tourette syndrome, associated conditions and the complexities of treatment. Brain 123:425\u2013462","journal-title":"Brain"},{"key":"17_CR43_17","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1097\/00004714-198812000-00021","volume":"8","author":"R Sandyk","year":"1988","unstructured":"Sandyk R, Awerbuch G (1988) Marijuana and Tourette\u2019s syndrome. J Clin Psychopharmacol 8:444\u2013445","journal-title":"J Clin Psychopharmacol"},{"key":"17_CR44_17","volume-title":"Gilles de la Tourette syndrome","author":"AK Shapiro","year":"1988","unstructured":"Shapiro AK, Shapiro ES, Young JG et al. (1988) Signs, symptoms, and clinical course. In: Shapiro AK, Shapiro ES, Young JG, Feinberg TE (eds) Gilles de la Tourette syndrome, 2nd edn. Raven Press, New York","edition":"2"},{"key":"17_CR45_17","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1212\/WNL.57.11.2108","volume":"57","author":"KA Sieradzan","year":"2001","unstructured":"Sieradzan KA, Fox SH, Hill M et al. (2001) Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study. Neurology 57:2108\u20132111","journal-title":"Neurology"},{"key":"17_CR46_17","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/1531-8257(200011)15:6<1051::AID-MDS1001>3.0.CO;2-L","volume":"15","author":"HS Singer","year":"2000","unstructured":"Singer HS (2000) Current issues in Tourette syndrome. Mov Disord 15:1051\u20131063","journal-title":"Mov Disord"},{"key":"17_CR47_17","first-page":"163","volume":"85","author":"HS Singer","year":"2001","unstructured":"Singer HS, Wendtlandt JT (2001) Neurochemistry and synaptic neurotransmission in Tourette syndrome. Adv Neurol 85:163\u2013178","journal-title":"Adv Neurol"},{"key":"17_CR48_17","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/0006-3223(94)00178-6","volume":"37","author":"N Solowij","year":"1995","unstructured":"Solowij N, Michie PT, Fox AM (1995) Differential impairments of selective attention due to frequency and duration of cannabis use. Biol Psychiatry 37:731\u2013739","journal-title":"Biol Psychiatry"},{"key":"17_CR49_17","first-page":"11","volume":"220","author":"P Strohbeck-K\u00fchner","year":"2007","unstructured":"Strohbeck-K\u00fchner P, Skopp G, Mattern R (2007) Fitness to drive in spite (because) of THC. Arch Kriminol 220:11\u201319","journal-title":"Arch Kriminol"},{"key":"17_CR50_17","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/archneur.1993.00540100012008","volume":"50","author":"The Tourette syndrome classification study group","year":"1993","unstructured":"The Tourette syndrome classification study group (1993) Definitions and classification of tic disorders. Arch Neurol 50:1013\u20131016","journal-title":"Arch Neurol"},{"key":"17_CR51_17","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.biopsych.2005.08.019","volume":"59","author":"ET Tzavara","year":"2006","unstructured":"Tzavara ET, Li DL, Moutsimilli L et al. (2006) Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications. Biol Psychiatry 59:508\u2013515","journal-title":"Biol Psychiatry"},{"key":"17_CR52_17","unstructured":"Zimmermann P, Fimm B (1989) Neuropsychologische Testbatterie zur Erfassung von Aufmerksamkeitsdefiziten. Psychologisches Institut der Universit\u00e4t Freiburg"}],"container-title":["Current Topics in Behavioral Neurosciences","Behavioral Neurobiology of the Endocannabinoid System"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-540-88955-7_17.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T02:09:34Z","timestamp":1606183774000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-540-88955-7_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"ISBN":["9783540889540","9783540889557"],"references-count":52,"URL":"https:\/\/doi.org\/10.1007\/978-3-540-88955-7_17","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"value":"1866-3370","type":"print"},{"value":"1866-3389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009]]}}}